KeyCorp Has Positive Outlook of INSP FY2027 Earnings

Inspire Medical Systems, Inc. (NYSE:INSP) – Stock analysts at KeyCorp lifted their FY2027 earnings per share (EPS) estimates for Inspire Medical Systems in a report issued on Sunday, January 25th. KeyCorp analyst B. Fishbin now forecasts that the company will post earnings of $2.12 per share for the year, up from their prior estimate of $2.07. KeyCorp currently has a “Sector Weight” rating on the stock. The consensus estimate for Inspire Medical Systems’ current full-year earnings is $2.16 per share.

INSP has been the subject of several other reports. Robert W. Baird increased their price objective on shares of Inspire Medical Systems from $125.00 to $180.00 and gave the company an “outperform” rating in a report on Thursday, December 4th. Wolfe Research raised Inspire Medical Systems from a “peer perform” rating to an “outperform” rating and set a $180.00 price objective on the stock in a research note on Tuesday, November 25th. Weiss Ratings restated a “sell (d)” rating on shares of Inspire Medical Systems in a report on Monday, December 29th. UBS Group set a $96.00 target price on Inspire Medical Systems in a report on Thursday. Finally, Oppenheimer downgraded shares of Inspire Medical Systems from an “outperform” rating to a “market perform” rating in a report on Thursday, January 22nd. Eight investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $133.47.

Inspire Medical Systems Stock Up 2.3%

Shares of INSP opened at $81.25 on Tuesday. Inspire Medical Systems has a 52-week low of $70.77 and a 52-week high of $203.12. The firm has a market capitalization of $2.36 billion, a PE ratio of 55.27, a P/E/G ratio of 8.08 and a beta of 0.72. The firm has a 50-day moving average price of $105.99 and a 200 day moving average price of $96.21.

Inspire Medical Systems (NYSE:INSP) last announced its earnings results on Monday, November 3rd. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.53. Inspire Medical Systems had a return on equity of 9.41% and a net margin of 5.05%.The firm had revenue of $224.50 million for the quarter, compared to the consensus estimate of $220.39 million. During the same quarter in the previous year, the business earned $0.60 EPS. The firm’s revenue for the quarter was up 10.5% on a year-over-year basis.

Hedge Funds Weigh In On Inspire Medical Systems

Institutional investors have recently modified their holdings of the company. CWM LLC increased its holdings in shares of Inspire Medical Systems by 216.1% during the 4th quarter. CWM LLC now owns 354 shares of the company’s stock worth $33,000 after purchasing an additional 242 shares during the period. Farther Finance Advisors LLC boosted its stake in Inspire Medical Systems by 310.1% in the 4th quarter. Farther Finance Advisors LLC now owns 1,948 shares of the company’s stock valued at $180,000 after buying an additional 1,473 shares in the last quarter. Choreo LLC bought a new stake in shares of Inspire Medical Systems in the 4th quarter worth about $413,000. V Square Quantitative Management LLC bought a new stake in Inspire Medical Systems during the fourth quarter worth about $40,000. Finally, Oak Thistle LLC acquired a new stake in Inspire Medical Systems during the 4th quarter valued at $673,000. Institutional investors own 94.91% of the company’s stock.

Insider Activity

In other news, Director Shawn Mccormick sold 2,000 shares of the company’s stock in a transaction on Friday, November 28th. The shares were sold at an average price of $127.48, for a total value of $254,960.00. Following the transaction, the director directly owned 26,046 shares of the company’s stock, valued at approximately $3,320,344.08. This represents a 7.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 2.30% of the stock is owned by company insiders.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.